[{"data":1,"prerenderedAt":1400},["ShallowReactive",2],{"mdc-4uqs3g-key":3},{"data":4,"body":5},{},{"type":6,"children":7},"root",[8,17,28,32,38,59,64,83,94,99,119,124,127,133,138,147,152,157,162,165,171,176,184,189,194,203,210,213,219,224,229,232,238,250,255,260,263,269,274,279,297,300,312,315,321,332,343,348,369,374,379,384,387,393,398,403,408,419,422,428,439,444,457,462,467,476,481,484,490,495,500,503,509,514,522,527,530,536,543,548,554,559,564,569,574,577,583,588,596,601,605,613,618,623,628,633,636,642,647,658,661,667,672,680,685,690,695,698,704,709,720,725,730,737,744,749,772,775,787,792,795,801,806,811,814,819,824,829,834,839,847,852,857,862,873,876,882,887,895,900,908,913,921,926,931,936,939,945,950,955,958,964,969,987,992,1000,1005,1010,1013,1018,1023,1034,1037,1043,1048,1052,1057,1062,1065,1071,1076,1079,1085,1090,1095,1098,1104,1109,1128,1133,1136,1141,1144,1150,1155,1158,1164,1169,1174,1177,1183,1194,1199,1204,1212,1217,1220,1225,1232,1237,1240,1246,1251,1256,1259,1265,1273,1278,1283,1286,1292,1297,1305,1310,1315,1320,1325,1328,1334,1339,1344,1352,1357,1368,1373,1376,1382,1387,1395],{"type":9,"tag":10,"props":11,"children":13},"element","h1",{"id":12},"fun-educational-summary",[14],{"type":15,"value":16},"text","🩸 Fun & Educational Summary",{"type":9,"tag":18,"props":19,"children":21},"h2",{"id":20},"mim8-a-next-generation-fviiia-mimetic-antibody-for-hemophilia-a",[22],{"type":9,"tag":23,"props":24,"children":25},"em",{},[26],{"type":15,"value":27},"Mim8: A next-generation FVIIIa-mimetic antibody for hemophilia A",{"type":9,"tag":29,"props":30,"children":31},"hr",{},[],{"type":9,"tag":10,"props":33,"children":35},{"id":34},"_1-big-picture-what-problem-is-this-paper-solving",[36],{"type":15,"value":37},"🧬 1) Big picture — what problem is this paper solving?",{"type":9,"tag":39,"props":40,"children":41},"p",{},[42,44,50,52,57],{"type":15,"value":43},"Hemophilia A is a ",{"type":9,"tag":45,"props":46,"children":47},"strong",{},[48],{"type":15,"value":49},"bleeding disorder",{"type":15,"value":51}," caused by ",{"type":9,"tag":45,"props":53,"children":54},{},[55],{"type":15,"value":56},"factor VIII (FVIII) deficiency",{"type":15,"value":58},".",{"type":9,"tag":39,"props":60,"children":61},{},[62],{"type":15,"value":63},"FVIII is one of the key proteins in the coagulation cascade.",{"type":9,"tag":39,"props":65,"children":66},{},[67,69,74,76,81],{"type":15,"value":68},"Normally, it helps blood clot by acting as a ",{"type":9,"tag":45,"props":70,"children":71},{},[72],{"type":15,"value":73},"cofactor",{"type":15,"value":75}," for activated factor IX (",{"type":9,"tag":45,"props":77,"children":78},{},[79],{"type":15,"value":80},"FIXa",{"type":15,"value":82},").",{"type":9,"tag":39,"props":84,"children":85},{},[86,88,93],{"type":15,"value":87},"Its main job is to help FIXa activate factor X (",{"type":9,"tag":45,"props":89,"children":90},{},[91],{"type":15,"value":92},"FX → FXa",{"type":15,"value":82},{"type":9,"tag":39,"props":95,"children":96},{},[97],{"type":15,"value":98},"That step is extremely important because it leads to:",{"type":9,"tag":100,"props":101,"children":102},"ul",{},[103,109,114],{"type":9,"tag":104,"props":105,"children":106},"li",{},[107],{"type":15,"value":108},"thrombin generation",{"type":9,"tag":104,"props":110,"children":111},{},[112],{"type":15,"value":113},"fibrin formation",{"type":9,"tag":104,"props":115,"children":116},{},[117],{"type":15,"value":118},"stable clot formation",{"type":9,"tag":39,"props":120,"children":121},{},[122],{"type":15,"value":123},"Without FVIII, patients bleed excessively.",{"type":9,"tag":29,"props":125,"children":126},{},[],{"type":9,"tag":18,"props":128,"children":130},{"id":129},"normal-reaction",[131],{"type":15,"value":132},"Normal reaction",{"type":9,"tag":39,"props":134,"children":135},{},[136],{"type":15,"value":137},"Very simplified:",{"type":9,"tag":39,"props":139,"children":140},{},[141],{"type":9,"tag":142,"props":143,"children":144},"span",{},[145],{"type":15,"value":146},"\nFIXa + FVIIIa + FX\rightarrow FXa\n",{"type":9,"tag":39,"props":148,"children":149},{},[150],{"type":15,"value":151},"FXa then helps convert prothrombin into thrombin.",{"type":9,"tag":39,"props":153,"children":154},{},[155],{"type":15,"value":156},"Thrombin then makes fibrin.",{"type":9,"tag":39,"props":158,"children":159},{},[160],{"type":15,"value":161},"That is how the clot forms.",{"type":9,"tag":29,"props":163,"children":164},{},[],{"type":9,"tag":18,"props":166,"children":168},{"id":167},"what-happens-in-hemophilia-a",[169],{"type":15,"value":170},"What happens in hemophilia A?",{"type":9,"tag":39,"props":172,"children":173},{},[174],{"type":15,"value":175},"Because FVIII is missing:",{"type":9,"tag":39,"props":177,"children":178},{},[179],{"type":9,"tag":142,"props":180,"children":181},{},[182],{"type":15,"value":183},"\nFIXa\not\rightarrow FXa \text{ efficiently}\n",{"type":9,"tag":39,"props":185,"children":186},{},[187],{"type":15,"value":188},"So clot formation becomes weak.",{"type":9,"tag":39,"props":190,"children":191},{},[192],{"type":15,"value":193},"Even small injuries can lead to severe bleeding.",{"type":9,"tag":39,"props":195,"children":196},{},[197],{"type":9,"tag":198,"props":199,"children":202},"img",{"alt":200,"src":201},"Image","https://d16qt3wv6xm098.cloudfront.net/LB_AfTCJQIWC7n-b7f7BTmKgQ3OmO9cx/_.png",[],{"type":9,"tag":39,"props":204,"children":205},{},[206],{"type":9,"tag":198,"props":207,"children":209},{"alt":200,"src":208},"https://www.researchgate.net/publication/327738246/figure/fig2/AS%3A672390333878273%401537321756040/Complete-coagulation-cascade-depicting-both-intrinsic-and-extrinsic-pathways-Hemophilia.png",[],{"type":9,"tag":29,"props":211,"children":212},{},[],{"type":9,"tag":10,"props":214,"children":216},{"id":215},"_2-why-is-this-clinically-important",[217],{"type":15,"value":218},"💉 2) Why is this clinically important?",{"type":9,"tag":39,"props":220,"children":221},{},[222],{"type":15,"value":223},"Traditional treatment is giving recombinant FVIII.",{"type":9,"tag":39,"props":225,"children":226},{},[227],{"type":15,"value":228},"But there are two major problems:",{"type":9,"tag":29,"props":230,"children":231},{},[],{"type":9,"tag":18,"props":233,"children":235},{"id":234},"problem-1-inhibitors",[236],{"type":15,"value":237},"Problem 1 — inhibitors",{"type":9,"tag":39,"props":239,"children":240},{},[241,243,248],{"type":15,"value":242},"Around ",{"type":9,"tag":45,"props":244,"children":245},{},[246],{"type":15,"value":247},"30% of patients develop neutralizing antibodies",{"type":15,"value":249}," against FVIII.",{"type":9,"tag":39,"props":251,"children":252},{},[253],{"type":15,"value":254},"That means the treatment protein gets blocked by the immune system.",{"type":9,"tag":39,"props":256,"children":257},{},[258],{"type":15,"value":259},"This is one of the biggest challenges in hemophilia therapy.",{"type":9,"tag":29,"props":261,"children":262},{},[],{"type":9,"tag":18,"props":264,"children":266},{"id":265},"problem-2-iv-injections",[267],{"type":15,"value":268},"Problem 2 — IV injections",{"type":9,"tag":39,"props":270,"children":271},{},[272],{"type":15,"value":273},"FVIII is typically given intravenously.",{"type":9,"tag":39,"props":275,"children":276},{},[277],{"type":15,"value":278},"That means:",{"type":9,"tag":100,"props":280,"children":281},{},[282,287,292],{"type":9,"tag":104,"props":283,"children":284},{},[285],{"type":15,"value":286},"repeated hospital/home injections",{"type":9,"tag":104,"props":288,"children":289},{},[290],{"type":15,"value":291},"difficult for children",{"type":9,"tag":104,"props":293,"children":294},{},[295],{"type":15,"value":296},"burdensome long-term prophylaxis",{"type":9,"tag":29,"props":298,"children":299},{},[],{"type":9,"tag":39,"props":301,"children":302},{},[303,305,310],{"type":15,"value":304},"This is why ",{"type":9,"tag":45,"props":306,"children":307},{},[308],{"type":15,"value":309},"emicizumab",{"type":15,"value":311}," was a breakthrough.",{"type":9,"tag":29,"props":313,"children":314},{},[],{"type":9,"tag":10,"props":316,"children":318},{"id":317},"_3-what-is-emicizumab",[319],{"type":15,"value":320},"🧠 3) What is emicizumab?",{"type":9,"tag":39,"props":322,"children":323},{},[324,326,331],{"type":15,"value":325},"Emicizumab is a ",{"type":9,"tag":45,"props":327,"children":328},{},[329],{"type":15,"value":330},"bispecific antibody",{"type":15,"value":58},{"type":9,"tag":39,"props":333,"children":334},{},[335,337,342],{"type":15,"value":336},"This means one antibody can bind ",{"type":9,"tag":45,"props":338,"children":339},{},[340],{"type":15,"value":341},"two different targets",{"type":15,"value":58},{"type":9,"tag":39,"props":344,"children":345},{},[346],{"type":15,"value":347},"In this case:",{"type":9,"tag":100,"props":349,"children":350},{},[351,360],{"type":9,"tag":104,"props":352,"children":353},{},[354,356],{"type":15,"value":355},"one arm binds ",{"type":9,"tag":45,"props":357,"children":358},{},[359],{"type":15,"value":80},{"type":9,"tag":104,"props":361,"children":362},{},[363,364],{"type":15,"value":355},{"type":9,"tag":45,"props":365,"children":366},{},[367],{"type":15,"value":368},"FX",{"type":9,"tag":39,"props":370,"children":371},{},[372],{"type":15,"value":373},"It acts like an artificial bridge.",{"type":9,"tag":39,"props":375,"children":376},{},[377],{"type":15,"value":378},"So instead of using FVIII protein, it physically brings FIXa and FX together.",{"type":9,"tag":39,"props":380,"children":381},{},[382],{"type":15,"value":383},"This mimics FVIIIa.",{"type":9,"tag":29,"props":385,"children":386},{},[],{"type":9,"tag":18,"props":388,"children":390},{"id":389},"very-simple-concept",[391],{"type":15,"value":392},"Very simple concept",{"type":9,"tag":39,"props":394,"children":395},{},[396],{"type":15,"value":397},"Think of FVIII as a “molecular matchmaker”.",{"type":9,"tag":39,"props":399,"children":400},{},[401],{"type":15,"value":402},"It brings two proteins close enough to react.",{"type":9,"tag":39,"props":404,"children":405},{},[406],{"type":15,"value":407},"Emicizumab does the same.",{"type":9,"tag":39,"props":409,"children":410},{},[411,413,418],{"type":15,"value":412},"Mim8 is a ",{"type":9,"tag":45,"props":414,"children":415},{},[416],{"type":15,"value":417},"better version of that idea",{"type":15,"value":58},{"type":9,"tag":29,"props":420,"children":421},{},[],{"type":9,"tag":10,"props":423,"children":425},{"id":424},"_4-so-what-is-mim8",[426],{"type":15,"value":427},"🚀 4) So what is Mim8?",{"type":9,"tag":39,"props":429,"children":430},{},[431,433,438],{"type":15,"value":432},"Mim8 is another ",{"type":9,"tag":45,"props":434,"children":435},{},[436],{"type":15,"value":437},"FVIIIa-mimetic bispecific antibody",{"type":15,"value":58},{"type":9,"tag":39,"props":440,"children":441},{},[442],{"type":15,"value":443},"Again:",{"type":9,"tag":100,"props":445,"children":446},{},[447,452],{"type":9,"tag":104,"props":448,"children":449},{},[450],{"type":15,"value":451},"one arm binds FIXa",{"type":9,"tag":104,"props":453,"children":454},{},[455],{"type":15,"value":456},"one arm binds FX",{"type":9,"tag":39,"props":458,"children":459},{},[460],{"type":15,"value":461},"BUT this paper aims to make it much stronger than emicizumab.",{"type":9,"tag":39,"props":463,"children":464},{},[465],{"type":15,"value":466},"The key idea is:",{"type":9,"tag":468,"props":469,"children":470},"blockquote",{},[471],{"type":9,"tag":39,"props":472,"children":473},{},[474],{"type":15,"value":475},"not only bridge the proteins\nbut also actively stimulate FIXa",{"type":9,"tag":39,"props":477,"children":478},{},[479],{"type":15,"value":480},"This is the big innovation.",{"type":9,"tag":29,"props":482,"children":483},{},[],{"type":9,"tag":10,"props":485,"children":487},{"id":486},"️-5-important-mechanistic-idea-mim8-does-more-than-bridge",[488],{"type":15,"value":489},"⚙️ 5) Important mechanistic idea — Mim8 does more than bridge",{"type":9,"tag":39,"props":491,"children":492},{},[493],{"type":15,"value":494},"This is the most important concept in the paper.",{"type":9,"tag":39,"props":496,"children":497},{},[498],{"type":15,"value":499},"Please focus on this part.",{"type":9,"tag":29,"props":501,"children":502},{},[],{"type":9,"tag":18,"props":504,"children":506},{"id":505},"emicizumab-mostly-works-as-a-bridge",[507],{"type":15,"value":508},"Emicizumab mostly works as a bridge",{"type":9,"tag":39,"props":510,"children":511},{},[512],{"type":15,"value":513},"It mainly helps:",{"type":9,"tag":39,"props":515,"children":516},{},[517],{"type":9,"tag":142,"props":518,"children":519},{},[520],{"type":15,"value":521},"\nFIXa + FX\n",{"type":9,"tag":39,"props":523,"children":524},{},[525],{"type":15,"value":526},"come together.",{"type":9,"tag":29,"props":528,"children":529},{},[],{"type":9,"tag":18,"props":531,"children":533},{"id":532},"mim8-does-two-things",[534],{"type":15,"value":535},"Mim8 does TWO things",{"type":9,"tag":537,"props":538,"children":540},"h3",{"id":539},"_1-bridges-fixa-and-fx",[541],{"type":15,"value":542},"(1) Bridges FIXa and FX",{"type":9,"tag":39,"props":544,"children":545},{},[546],{"type":15,"value":547},"Like emicizumab",{"type":9,"tag":537,"props":549,"children":551},{"id":550},"_2-stimulates-fixa-catalytic-activity",[552],{"type":15,"value":553},"(2) Stimulates FIXa catalytic activity",{"type":9,"tag":39,"props":555,"children":556},{},[557],{"type":15,"value":558},"This is the new part",{"type":9,"tag":39,"props":560,"children":561},{},[562],{"type":15,"value":563},"The anti-FIXa arm itself allosterically enhances FIXa.",{"type":9,"tag":39,"props":565,"children":566},{},[567],{"type":15,"value":568},"This dramatically increases FX activation.",{"type":9,"tag":39,"props":570,"children":571},{},[572],{"type":15,"value":573},"That is why Mim8 is much stronger.",{"type":9,"tag":29,"props":575,"children":576},{},[],{"type":9,"tag":10,"props":578,"children":580},{"id":579},"_6-the-most-impressive-result-4-orders-of-magnitude-boost",[581],{"type":15,"value":582},"🔥 6) The most impressive result — 4 orders of magnitude boost",{"type":9,"tag":39,"props":584,"children":585},{},[586],{"type":15,"value":587},"The paper reports that the anti-FIXa arm enhances FIXa activity by:",{"type":9,"tag":39,"props":589,"children":590},{},[591],{"type":9,"tag":142,"props":592,"children":593},{},[594],{"type":15,"value":595},"\n10^4\n",{"type":9,"tag":39,"props":597,"children":598},{},[599],{"type":15,"value":600},"fold",{"type":9,"tag":39,"props":602,"children":603},{},[604],{"type":15,"value":278},{"type":9,"tag":39,"props":606,"children":607},{},[608],{"type":9,"tag":142,"props":609,"children":610},{},[611],{"type":15,"value":612},"\n10,000\times\n",{"type":9,"tag":39,"props":614,"children":615},{},[616],{"type":15,"value":617},"increase.",{"type":9,"tag":39,"props":619,"children":620},{},[621],{"type":15,"value":622},"That is huge.",{"type":9,"tag":39,"props":624,"children":625},{},[626],{"type":15,"value":627},"Later after optimization they report even larger stimulation in some assays.",{"type":9,"tag":39,"props":629,"children":630},{},[631],{"type":15,"value":632},"This is the major reason Mim8 is so potent.",{"type":9,"tag":29,"props":634,"children":635},{},[],{"type":9,"tag":10,"props":637,"children":639},{"id":638},"_7-how-did-they-develop-it",[640],{"type":15,"value":641},"🧪 7) How did they develop it?",{"type":9,"tag":39,"props":643,"children":644},{},[645],{"type":15,"value":646},"This section is very interesting scientifically.",{"type":9,"tag":39,"props":648,"children":649},{},[650,652,657],{"type":15,"value":651},"They did ",{"type":9,"tag":45,"props":653,"children":654},{},[655],{"type":15,"value":656},"large-scale antibody engineering",{"type":15,"value":58},{"type":9,"tag":29,"props":659,"children":660},{},[],{"type":9,"tag":18,"props":662,"children":664},{"id":663},"step-1-huge-screening-library",[665],{"type":15,"value":666},"Step 1 — huge screening library",{"type":9,"tag":39,"props":668,"children":669},{},[670],{"type":15,"value":671},"They screened:",{"type":9,"tag":39,"props":673,"children":674},{},[675],{"type":9,"tag":142,"props":676,"children":677},{},[678],{"type":15,"value":679},"\n100 \times 100\n",{"type":9,"tag":39,"props":681,"children":682},{},[683],{"type":15,"value":684},"combinations of anti-FIXa and anti-FX antibodies.",{"type":9,"tag":39,"props":686,"children":687},{},[688],{"type":15,"value":689},"That means thousands of combinations.",{"type":9,"tag":39,"props":691,"children":692},{},[693],{"type":15,"value":694},"Each pair was tested for thrombin generation.",{"type":9,"tag":29,"props":696,"children":697},{},[],{"type":9,"tag":18,"props":699,"children":701},{"id":700},"step-2-mutational-optimization",[702],{"type":15,"value":703},"Step 2 — mutational optimization",{"type":9,"tag":39,"props":705,"children":706},{},[707],{"type":15,"value":708},"This is classic protein engineering / antibody engineering.",{"type":9,"tag":39,"props":710,"children":711},{},[712,714,719],{"type":15,"value":713},"They introduced mutations mainly in the ",{"type":9,"tag":45,"props":715,"children":716},{},[717],{"type":15,"value":718},"CDR loops",{"type":15,"value":58},{"type":9,"tag":39,"props":721,"children":722},{},[723],{"type":15,"value":724},"CDRs = complementarity-determining regions.",{"type":9,"tag":39,"props":726,"children":727},{},[728],{"type":15,"value":729},"These are the binding loops of antibodies.",{"type":9,"tag":39,"props":731,"children":732},{},[733],{"type":9,"tag":198,"props":734,"children":736},{"alt":200,"src":735},"https://www.researchgate.net/publication/381109063/figure/fig1/AS%3A11431281248821914%401717391875118/Left-Overview-of-an-antibody-structure-with-the-variable-region-and-CDR-loops-shown.ppm",[],{"type":9,"tag":39,"props":738,"children":739},{},[740],{"type":9,"tag":198,"props":741,"children":743},{"alt":200,"src":742},"https://www.biointron.com/static/upload/image/20240905/1725472898155614.jpg",[],{"type":9,"tag":39,"props":745,"children":746},{},[747],{"type":15,"value":748},"These regions determine:",{"type":9,"tag":100,"props":750,"children":751},{},[752,757,762,767],{"type":9,"tag":104,"props":753,"children":754},{},[755],{"type":15,"value":756},"affinity",{"type":9,"tag":104,"props":758,"children":759},{},[760],{"type":15,"value":761},"specificity",{"type":9,"tag":104,"props":763,"children":764},{},[765],{"type":15,"value":766},"activity",{"type":9,"tag":104,"props":768,"children":769},{},[770],{"type":15,"value":771},"developability",{"type":9,"tag":29,"props":773,"children":774},{},[],{"type":9,"tag":39,"props":776,"children":777},{},[778,780,785],{"type":15,"value":779},"They tested ",{"type":9,"tag":45,"props":781,"children":782},{},[783],{"type":15,"value":784},"4056 variants",{"type":15,"value":786}," of the anti-FIXa arm.",{"type":9,"tag":39,"props":788,"children":789},{},[790],{"type":15,"value":791},"That is a serious optimization campaign.",{"type":9,"tag":29,"props":793,"children":794},{},[],{"type":9,"tag":10,"props":796,"children":798},{"id":797},"_8-very-important-concept-the-hook-effect",[799],{"type":15,"value":800},"🧬 8) Very important concept — the hook effect",{"type":9,"tag":39,"props":802,"children":803},{},[804],{"type":15,"value":805},"This is a key concept in bispecific antibodies.",{"type":9,"tag":39,"props":807,"children":808},{},[809],{"type":15,"value":810},"The paper mentions it multiple times.",{"type":9,"tag":29,"props":812,"children":813},{},[],{"type":9,"tag":39,"props":815,"children":816},{},[817],{"type":15,"value":818},"At moderate concentration → best activity",{"type":9,"tag":39,"props":820,"children":821},{},[822],{"type":15,"value":823},"At very high concentration → activity drops",{"type":9,"tag":39,"props":825,"children":826},{},[827],{"type":15,"value":828},"Why?",{"type":9,"tag":39,"props":830,"children":831},{},[832],{"type":15,"value":833},"Because too many antibodies separately bind FIXa and FX.",{"type":9,"tag":39,"props":835,"children":836},{},[837],{"type":15,"value":838},"So instead of making:",{"type":9,"tag":39,"props":840,"children":841},{},[842],{"type":9,"tag":142,"props":843,"children":844},{},[845],{"type":15,"value":846},"\nFIXa - Mim8 - FX\n",{"type":9,"tag":39,"props":848,"children":849},{},[850],{"type":15,"value":851},"complexes,",{"type":9,"tag":39,"props":853,"children":854},{},[855],{"type":15,"value":856},"they trap proteins in separate nonproductive complexes.",{"type":9,"tag":39,"props":858,"children":859},{},[860],{"type":15,"value":861},"This reduces function.",{"type":9,"tag":39,"props":863,"children":864},{},[865,867,872],{"type":15,"value":866},"This is called the ",{"type":9,"tag":45,"props":868,"children":869},{},[870],{"type":15,"value":871},"hook effect",{"type":15,"value":58},{"type":9,"tag":29,"props":874,"children":875},{},[],{"type":9,"tag":18,"props":877,"children":879},{"id":878},"conceptually",[880],{"type":15,"value":881},"Conceptually",{"type":9,"tag":39,"props":883,"children":884},{},[885],{"type":15,"value":886},"Good:",{"type":9,"tag":39,"props":888,"children":889},{},[890],{"type":9,"tag":142,"props":891,"children":892},{},[893],{"type":15,"value":894},"\nFIXa leftrightarrow Mim8 leftrightarrow FX\n",{"type":9,"tag":39,"props":896,"children":897},{},[898],{"type":15,"value":899},"Bad:",{"type":9,"tag":39,"props":901,"children":902},{},[903],{"type":9,"tag":142,"props":904,"children":905},{},[906],{"type":15,"value":907},"\nFIXa leftrightarrow Mim8\n",{"type":9,"tag":39,"props":909,"children":910},{},[911],{"type":15,"value":912},"and separately",{"type":9,"tag":39,"props":914,"children":915},{},[916],{"type":9,"tag":142,"props":917,"children":918},{},[919],{"type":15,"value":920},"\nFX leftrightarrow Mim8\n",{"type":9,"tag":39,"props":922,"children":923},{},[924],{"type":15,"value":925},"No productive bridging.",{"type":9,"tag":39,"props":927,"children":928},{},[929],{"type":15,"value":930},"This is why activity drops at excessive dose.",{"type":9,"tag":39,"props":932,"children":933},{},[934],{"type":15,"value":935},"Very important pharmacology concept.",{"type":9,"tag":29,"props":937,"children":938},{},[],{"type":9,"tag":10,"props":940,"children":942},{"id":941},"_9-structural-biology-where-does-mim8-bind",[943],{"type":15,"value":944},"🧱 9) Structural biology — where does Mim8 bind?",{"type":9,"tag":39,"props":946,"children":947},{},[948],{"type":15,"value":949},"This part is excellent for structural biophysics.",{"type":9,"tag":39,"props":951,"children":952},{},[953],{"type":15,"value":954},"The authors solved crystal structures.",{"type":9,"tag":29,"props":956,"children":957},{},[],{"type":9,"tag":18,"props":959,"children":961},{"id":960},"fixa-binding-site",[962],{"type":15,"value":963},"FIXa binding site",{"type":9,"tag":39,"props":965,"children":966},{},[967],{"type":15,"value":968},"The anti-FIXa Fab binds near:",{"type":9,"tag":100,"props":970,"children":971},{},[972,977,982],{"type":9,"tag":104,"props":973,"children":974},{},[975],{"type":15,"value":976},"170 loop",{"type":9,"tag":104,"props":978,"children":979},{},[980],{"type":15,"value":981},"160 helix",{"type":9,"tag":104,"props":983,"children":984},{},[985],{"type":15,"value":986},"activation loop region",{"type":9,"tag":39,"props":988,"children":989},{},[990],{"type":15,"value":991},"Importantly:",{"type":9,"tag":468,"props":993,"children":994},{},[995],{"type":9,"tag":39,"props":996,"children":997},{},[998],{"type":15,"value":999},"it does NOT block the active site",{"type":9,"tag":39,"props":1001,"children":1002},{},[1003],{"type":15,"value":1004},"This is crucial.",{"type":9,"tag":39,"props":1006,"children":1007},{},[1008],{"type":15,"value":1009},"Because FX still needs access.",{"type":9,"tag":29,"props":1011,"children":1012},{},[],{"type":9,"tag":39,"props":1014,"children":1015},{},[1016],{"type":15,"value":1017},"This is elegant molecular design.",{"type":9,"tag":39,"props":1019,"children":1020},{},[1021],{"type":15,"value":1022},"It stimulates FIXa without sterically blocking catalysis.",{"type":9,"tag":39,"props":1024,"children":1025},{},[1026,1028,1033],{"type":15,"value":1027},"As a structural biology learner, this is a beautiful example of ",{"type":9,"tag":45,"props":1029,"children":1030},{},[1031],{"type":15,"value":1032},"allosteric engineering",{"type":15,"value":58},{"type":9,"tag":29,"props":1035,"children":1036},{},[],{"type":9,"tag":18,"props":1038,"children":1040},{"id":1039},"fx-binding-site",[1041],{"type":15,"value":1042},"FX binding site",{"type":9,"tag":39,"props":1044,"children":1045},{},[1046],{"type":15,"value":1047},"Similarly, the FX arm binds in a way that still allows activation.",{"type":9,"tag":39,"props":1049,"children":1050},{},[1051],{"type":15,"value":443},{"type":9,"tag":39,"props":1053,"children":1054},{},[1055],{"type":15,"value":1056},"functional binding without blocking catalysis.",{"type":9,"tag":39,"props":1058,"children":1059},{},[1060],{"type":15,"value":1061},"Very smart design.",{"type":9,"tag":29,"props":1063,"children":1064},{},[],{"type":9,"tag":10,"props":1066,"children":1068},{"id":1067},"_10-plasma-and-whole-blood-results",[1069],{"type":15,"value":1070},"🩸 10) Plasma and whole blood results",{"type":9,"tag":39,"props":1072,"children":1073},{},[1074],{"type":15,"value":1075},"This is where the translational relevance becomes very strong.",{"type":9,"tag":29,"props":1077,"children":1078},{},[],{"type":9,"tag":18,"props":1080,"children":1082},{"id":1081},"thrombin-generation-assay",[1083],{"type":15,"value":1084},"Thrombin generation assay",{"type":9,"tag":39,"props":1086,"children":1087},{},[1088],{"type":15,"value":1089},"Mim8 normalized thrombin generation in hemophilia A plasma.",{"type":9,"tag":39,"props":1091,"children":1092},{},[1093],{"type":15,"value":1094},"This means it restored clotting function.",{"type":9,"tag":29,"props":1096,"children":1097},{},[],{"type":9,"tag":18,"props":1099,"children":1101},{"id":1100},"compared-with-emicizumab",[1102],{"type":15,"value":1103},"Compared with emicizumab",{"type":9,"tag":39,"props":1105,"children":1106},{},[1107],{"type":15,"value":1108},"The potency was:",{"type":9,"tag":100,"props":1110,"children":1111},{},[1112,1120],{"type":9,"tag":104,"props":1113,"children":1114},{},[1115],{"type":9,"tag":45,"props":1116,"children":1117},{},[1118],{"type":15,"value":1119},"13× higher in plasma",{"type":9,"tag":104,"props":1121,"children":1122},{},[1123],{"type":9,"tag":45,"props":1124,"children":1125},{},[1126],{"type":15,"value":1127},"18× higher in whole blood",{"type":9,"tag":39,"props":1129,"children":1130},{},[1131],{"type":15,"value":1132},"These are very strong results.",{"type":9,"tag":29,"props":1134,"children":1135},{},[],{"type":9,"tag":39,"props":1137,"children":1138},{},[1139],{"type":15,"value":1140},"This strongly suggests lower effective dosing may be possible.",{"type":9,"tag":29,"props":1142,"children":1143},{},[],{"type":9,"tag":10,"props":1145,"children":1147},{"id":1146},"_11-mouse-bleeding-model-extremely-important",[1148],{"type":15,"value":1149},"🐭 11) Mouse bleeding model — extremely important",{"type":9,"tag":39,"props":1151,"children":1152},{},[1153],{"type":15,"value":1154},"This is probably the most exciting part biologically.",{"type":9,"tag":29,"props":1156,"children":1157},{},[],{"type":9,"tag":18,"props":1159,"children":1161},{"id":1160},"tail-vein-transection-model",[1162],{"type":15,"value":1163},"Tail vein transection model",{"type":9,"tag":39,"props":1165,"children":1166},{},[1167],{"type":15,"value":1168},"Moderate bleeding injury model.",{"type":9,"tag":39,"props":1170,"children":1171},{},[1172],{"type":15,"value":1173},"Mim8 reduced blood loss much more effectively than emicizumab.",{"type":9,"tag":29,"props":1175,"children":1176},{},[],{"type":9,"tag":18,"props":1178,"children":1180},{"id":1179},"tail-clip-model",[1181],{"type":15,"value":1182},"Tail clip model",{"type":9,"tag":39,"props":1184,"children":1185},{},[1186,1188,1193],{"type":15,"value":1187},"This is a ",{"type":9,"tag":45,"props":1189,"children":1190},{},[1191],{"type":15,"value":1192},"severe vascular challenge",{"type":15,"value":58},{"type":9,"tag":39,"props":1195,"children":1196},{},[1197],{"type":15,"value":1198},"Much harsher bleeding model.",{"type":9,"tag":39,"props":1200,"children":1201},{},[1202],{"type":15,"value":1203},"The key result:",{"type":9,"tag":468,"props":1205,"children":1206},{},[1207],{"type":9,"tag":39,"props":1208,"children":1209},{},[1210],{"type":15,"value":1211},"Mim8 worked\nemicizumab did not significantly reduce bleeding",{"type":9,"tag":39,"props":1213,"children":1214},{},[1215],{"type":15,"value":1216},"This is the headline result of the paper.",{"type":9,"tag":29,"props":1218,"children":1219},{},[],{"type":9,"tag":39,"props":1221,"children":1222},{},[1223],{"type":15,"value":1224},"That is why the title emphasizes:",{"type":9,"tag":468,"props":1226,"children":1227},{},[1228],{"type":9,"tag":39,"props":1229,"children":1230},{},[1231],{"type":15,"value":1192},{"type":9,"tag":39,"props":1233,"children":1234},{},[1235],{"type":15,"value":1236},"This is a much tougher efficacy test.",{"type":9,"tag":29,"props":1238,"children":1239},{},[],{"type":9,"tag":10,"props":1241,"children":1243},{"id":1242},"_12-pharmacokinetics",[1244],{"type":15,"value":1245},"🧪 12) Pharmacokinetics",{"type":9,"tag":39,"props":1247,"children":1248},{},[1249],{"type":15,"value":1250},"They tested PK in cynomolgus monkeys.",{"type":9,"tag":39,"props":1252,"children":1253},{},[1254],{"type":15,"value":1255},"Very important for drug development.",{"type":9,"tag":29,"props":1257,"children":1258},{},[],{"type":9,"tag":18,"props":1260,"children":1262},{"id":1261},"half-life",[1263],{"type":15,"value":1264},"Half-life",{"type":9,"tag":39,"props":1266,"children":1267},{},[1268],{"type":9,"tag":142,"props":1269,"children":1270},{},[1271],{"type":15,"value":1272},"\nt_{1/2} = 14 \text{ days}\n",{"type":9,"tag":39,"props":1274,"children":1275},{},[1276],{"type":15,"value":1277},"This is excellent.",{"type":9,"tag":39,"props":1279,"children":1280},{},[1281],{"type":15,"value":1282},"Comparable to long-acting biologics.",{"type":9,"tag":29,"props":1284,"children":1285},{},[],{"type":9,"tag":18,"props":1287,"children":1289},{"id":1288},"subcutaneous-bioavailability",[1290],{"type":15,"value":1291},"Subcutaneous bioavailability",{"type":9,"tag":39,"props":1293,"children":1294},{},[1295],{"type":15,"value":1296},"They report:",{"type":9,"tag":39,"props":1298,"children":1299},{},[1300],{"type":9,"tag":142,"props":1301,"children":1302},{},[1303],{"type":15,"value":1304},"\n97%\n",{"type":9,"tag":39,"props":1306,"children":1307},{},[1308],{"type":15,"value":1309},"Very high.",{"type":9,"tag":39,"props":1311,"children":1312},{},[1313],{"type":15,"value":1314},"This is clinically attractive.",{"type":9,"tag":39,"props":1316,"children":1317},{},[1318],{"type":15,"value":1319},"Patients can use SC dosing instead of IV.",{"type":9,"tag":39,"props":1321,"children":1322},{},[1323],{"type":15,"value":1324},"Huge advantage.",{"type":9,"tag":29,"props":1326,"children":1327},{},[],{"type":9,"tag":10,"props":1329,"children":1331},{"id":1330},"_13-why-this-paper-is-scientifically-important",[1332],{"type":15,"value":1333},"🎯 13) Why this paper is scientifically important",{"type":9,"tag":39,"props":1335,"children":1336},{},[1337],{"type":15,"value":1338},"This is more than “another better drug”.",{"type":9,"tag":39,"props":1340,"children":1341},{},[1342],{"type":15,"value":1343},"It demonstrates a major concept:",{"type":9,"tag":468,"props":1345,"children":1346},{},[1347],{"type":9,"tag":39,"props":1348,"children":1349},{},[1350],{"type":15,"value":1351},"antibody engineering can mimic enzyme cofactors",{"type":9,"tag":39,"props":1353,"children":1354},{},[1355],{"type":15,"value":1356},"That is a very powerful therapeutic principle.",{"type":9,"tag":39,"props":1358,"children":1359},{},[1360,1362,1367],{"type":15,"value":1361},"Instead of replacing missing proteins directly, we can design ",{"type":9,"tag":45,"props":1363,"children":1364},{},[1365],{"type":15,"value":1366},"functional molecular mimics",{"type":15,"value":58},{"type":9,"tag":39,"props":1369,"children":1370},{},[1371],{"type":15,"value":1372},"This is advanced protein engineering.",{"type":9,"tag":29,"props":1374,"children":1375},{},[],{"type":9,"tag":10,"props":1377,"children":1379},{"id":1378},"core-take-home-message",[1380],{"type":15,"value":1381},"🧠 Core take-home message",{"type":9,"tag":39,"props":1383,"children":1384},{},[1385],{"type":15,"value":1386},"The simplest summary is:",{"type":9,"tag":468,"props":1388,"children":1389},{},[1390],{"type":9,"tag":39,"props":1391,"children":1392},{},[1393],{"type":15,"value":1394},"Mim8 is a next-generation bispecific antibody that mimics FVIIIa better than emicizumab by both bridging FIXa and FX and allosterically stimulating FIXa activity.",{"type":9,"tag":39,"props":1396,"children":1397},{},[1398],{"type":15,"value":1399},"That dual mechanism is why it is so potent.",1775084294644]